Can a Mouse Be Cloned Indefinitely? Decades-Long Experiment Has Answers

Why It Matters

The study shows that cloning cannot indefinitely maintain a pristine genome, challenging the viability of cloning for livestock improvement and conservation. It highlights the need for alternative strategies to preserve genetic quality in asexual propagation.

Key Takeaways

• Cloning succeeded up to 58 generations before failure
• Mutations accumulated, including whole chromosome loss
• Findings suggest limits for asexual mammalian reproduction
• Implications for livestock cloning and genetic resource preservation
• Researchers explore alternative cell sources like urine and feces

Pulse Analysis

The first successful mouse clone in 1997 demonstrated that a somatic cell nucleus could re‑program a fertilized egg, opening a new frontier for reproductive biology. Building on that breakthrough, Teruhiko Wakayama’s laboratory embarked on a 20‑year, 30,000‑attempt project to test whether a single genome could be perpetuated indefinitely through serial cloning. By repeatedly transferring nuclei from cloned offspring into fresh oocytes, the team generated a continuous lineage that reached 58 generations before the process stalled. This unprecedented scale provides the most comprehensive data set on the durability of asexual mammalian reproduction.

The study revealed a rapid rise in de novo mutations, including large‑scale chromosomal deletions, as the lineage progressed. Such genomic erosion is absent in sexually reproducing populations, where recombination and outcrossing purge harmful variants. The accumulation of irreversible DNA damage explains why cloning attempts beyond the 58th generation failed, confirming a biological ceiling for asexual propagation in vertebrates. For the livestock industry, which eyes cloning to lock in elite traits, the findings warn that genetic quality will degrade over time, potentially offsetting the economic benefits of cloned herds.

Despite the limitations, the research underscores the value of preserving genetic material in unconventional formats. Wakayama’s experiments with freeze‑dried sperm, cells from urine, and even feces illustrate pathways for long‑term biobanking without live animals. As biotechnology advances, integrating genome editing with cloning could mitigate mutation buildup, but ethical and regulatory hurdles remain. Understanding the mutational dynamics of cloned lines will be crucial for applications ranging from endangered‑species rescue to pharmaceutical protein production, ensuring that the promise of cloning is balanced by realistic expectations of genetic stability.